Lifecore Biomedical, Inc.

NasdaqGS:LFCR Stock Report

Market Cap: US$275.5m

Lifecore Biomedical Future Growth

Future criteria checks 1/6

Lifecore Biomedical's earnings are forecast to decline at 40.1% per annum while its annual revenue is expected to grow at 9.1% per year. EPS is expected to decline by 38.4% per annum.

Key information

-40.1%

Earnings growth rate

-38.4%

EPS growth rate

Life Sciences earnings growth18.4%
Revenue growth rate9.1%
Future return on equityn/a
Analyst coverage

Low

Last updated21 Nov 2024

Recent future growth updates

Recent updates

Lifecore Biomedical: Finally A 'Pure Play' CDMO Business

Nov 12

Lifecore Biomedical: No Sale Soon Amidst Leverage And Uncertainty

Jun 24

White Falcon Capital - Lifecore Biomedical: Potential For Rapid Growth In Earnings And FCF Surge

Apr 20

Would Lifecore Biomedical (NASDAQ:LFCR) Be Better Off With Less Debt?

Jun 30
Would Lifecore Biomedical (NASDAQ:LFCR) Be Better Off With Less Debt?

Landec Non-GAAP EPS of -$0.32, revenue of $43.35M

Oct 06

Landec receives Nasdaq's notification on delayed annual report filing

Sep 09

Laughing Water Capital - Landec Corp. : A High Quality CDMO

Jul 27

Landec (NASDAQ:LNDC) Takes On Some Risk With Its Use Of Debt

Jun 24
Landec (NASDAQ:LNDC) Takes On Some Risk With Its Use Of Debt

Analysts Have Been Trimming Their Landec Corporation (NASDAQ:LNDC) Price Target After Its Latest Report

Apr 08
Analysts Have Been Trimming Their Landec Corporation (NASDAQ:LNDC) Price Target After Its Latest Report

Landec (NASDAQ:LNDC) Has A Somewhat Strained Balance Sheet

Mar 21
Landec (NASDAQ:LNDC) Has A Somewhat Strained Balance Sheet

Here's What's Concerning About Landec's (NASDAQ:LNDC) Returns On Capital

Nov 30
Here's What's Concerning About Landec's (NASDAQ:LNDC) Returns On Capital

Optimistic About Landec's Strategic Initiatives And Sodium Hyaluronate Products

Nov 05

Earnings and Revenue Growth Forecasts

NasdaqGS:LFCR - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
5/31/2027155-220N/A3
5/31/2026139-24-10N/A3
5/31/2025129-31-21N/A3
8/25/20241286-97N/A
5/26/20241289-180N/A
2/25/2024122-21-34-11N/A
11/26/2023112-47-45-21N/A
8/27/2023104-70-48-25N/A
5/28/2023103-64-39-17N/A
2/26/202393-31-41-16N/A
11/27/2022104-27-46-22N/A
8/28/202293-15-50-25N/A
5/29/2022111-15-53-23N/A
2/27/2022135-12-49-18N/A
11/28/2021142-7-37-8N/A
8/29/202178-6-28-1N/A
5/30/2021101-23-916N/A
2/28/2021283-24-18-2N/A
11/29/2020391-34-216N/A
8/30/2020587-44-165N/A
5/31/2020160-22-44-17N/A
2/23/2020587-23-39-6N/A
11/24/2019590-10-46-4N/A
8/25/2019572-3-328N/A
5/26/20195582-2916N/A
2/24/20195468-2917N/A
11/25/201853523-2418N/A
8/26/201853324-2419N/A
5/27/201852426N/A20N/A
2/25/201844821N/A27N/A
11/26/20174408N/A31N/A
8/27/20174539N/A27N/A
5/28/201747010N/A30N/A
2/26/201754013N/A39N/A
11/27/2016534-12N/A25N/A
8/28/2016538-11N/A30N/A
5/29/2016477-12N/A21N/A
2/28/2016540-12N/A19N/A
11/29/201554913N/A25N/A
8/30/201554114N/A20N/A
5/31/201553914N/A27N/A
3/1/201552614N/A21N/A
11/30/201451417N/A20N/A
8/31/201450117N/A20N/A
5/25/201447719N/A21N/A
2/23/201446319N/A22N/A
11/24/201345418N/A23N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LFCR's earnings are forecast to decline over the next 3 years (-40.1% per year).

Earnings vs Market: LFCR's earnings are forecast to decline over the next 3 years (-40.1% per year).

High Growth Earnings: LFCR's earnings are forecast to decline over the next 3 years.

Revenue vs Market: LFCR's revenue (9.1% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: LFCR's revenue (9.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if LFCR's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y